Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Maidstone Hospital · Royal Marsden Hospital · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,711
total citations
- FWCI
- 26.70
- Percentile
- 100%
- References
- 30
Citations per year
Authors
14Topics & keywords
Topics
Keywords
- Medicine
- Cardiotoxicity
- Mucositis
- Doxorubicin
- Metastatic breast cancer
- Internal medicine
- Anthracycline
- Vomiting
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.